Skip to main content
. 2020 Jun 23;158(4):1665–1668. doi: 10.1016/j.chest.2020.06.023

Table 1.

Patient Demographics, Laboratory Values, and Hospitalization Timeline

Age, y Sex At Index Admission
Days Between Admissions, No. At Re-presentation
Evidence of Thrombosis During Re-presentation Death (Cause)
Length of Stay, d Last C-Reactive Protein, mg/L Last D-Dimer, ng/mL C-Reactive Protein, mg/L D-Dimer, ng/mL
81 F 4 3 450 3 173 858 NSTEMI, decreased EF Y (ARDS, withdrawal)
85 M 3 39 757 7 142 9,334 New RBBB and RAD Y (cardiogenic, shock)
69 M 1 147 118 4 258 181 NSTEMI Y (ARDS, shock)
75 F 4 54 699 6 118 >10,000 Never evaluated for VTE Y (shock)
68 M 7 206 586 1 Never evaluated for VTE Y (unknown)
71 M 4 255 7 173 428 Stroke Y (ARDS, shock)
69 F 2 13 121 3 100 273 NSTEMI, decreased EF Y (cardiogenic, shock)
69 M 2 3 386 Never evaluated for VTE Y (ARDS, shock)
80 M 3 170 350 8 39 4,681 Bilateral LE DVT N

CRP = C-reactive protein; EF = ejection fraction; F = female; LE = lower extremity; LOS = length of stay; M = male; N = no; NSTEMI = non ST segment myocardial infarction; RAD = right axis deviation; RBBB = right bundle branch block; Y = yes.